$GNPX
Genprex Inc

2018 Q2 Form 10-Q Financial Statement

#000156459018013661 Filed on May 15, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2018 Q1 2017 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.920M $630.0K $680.0K
YoY Change 448.15% -7.35% 151.85%
% of Gross Profit
Research & Development $113.0K $51.62K $68.36K
YoY Change 7.61% -24.49% 13.94%
% of Gross Profit
Depreciation & Amortization $1.171K $947.00 $597.00
YoY Change 58.63%
% of Gross Profit
Operating Expenses $113.0K $51.62K $68.36K
YoY Change 7.61% -24.49% -78.64%
Operating Profit -$6.036M -$686.6K -$751.3K
YoY Change 411.02% -8.61%
Interest Expense $30.58K $7.398K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.060M -$690.0K -$750.0K
YoY Change 413.56% -8.0% 134.38%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$6.061M -$694.0K -$751.3K
YoY Change 413.15% -7.63% 134.78%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$448.6K -$58.77K -$46.32K
COMMON SHARES
Basic Shares Outstanding 13.90M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.00M $20.00K $930.0K
YoY Change 2453.19% -97.85%
Cash & Equivalents $12.00M $24.49K $930.0K
Short-Term Investments
Other Short-Term Assets $540.0K $30.00K $20.00K
YoY Change 1700.0% 50.0%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.54M $58.40K $950.0K
YoY Change 2408.0% -93.85%
LONG-TERM ASSETS
Property, Plant & Equipment $10.00K $8.326K $10.00K
YoY Change 0.0% -16.74%
Goodwill
YoY Change
Intangibles $323.1K $307.6K
YoY Change
Long-Term Investments
YoY Change
Other Assets $336.6K $1.320M $50.00K
YoY Change 52.98% 2539.32%
Total Long-Term Assets $350.9K $1.328M $330.0K
YoY Change -31.19% 302.42%
TOTAL ASSETS
Total Short-Term Assets $12.54M $58.40K $950.0K
Total Long-Term Assets $350.9K $1.328M $330.0K
Total Assets $12.89M $1.386M $1.280M
YoY Change 1176.33% 8.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $300.0K $1.150M $140.0K
YoY Change 76.47% 721.43%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $280.0K $30.00K
YoY Change -100.0% 833.33%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $300.5K $1.428M $170.0K
YoY Change 43.11% 740.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $300.5K $1.428M $170.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $300.0K $1.430M $170.0K
YoY Change 42.86% 741.18%
SHAREHOLDERS EQUITY
Retained Earnings -$24.21M -$18.15M
YoY Change
Common Stock $13.90K $11.76K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.59M -$41.92K $1.110M
YoY Change
Total Liabilities & Shareholders Equity $12.89M $1.386M $1.280M
YoY Change 1176.33% 8.31%

Cashflow Statement

Concept 2018 Q2 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$6.061M -$694.0K -$751.3K
YoY Change 413.15% -7.63% 134.78%
Depreciation, Depletion And Amortization $1.171K $947.00 $597.00
YoY Change 58.63%
Cash From Operating Activities -$3.110M -$203.7K -$649.3K
YoY Change 364.18% -68.63% 305.82%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $1.469K $2.751K
YoY Change 0.0% -46.6%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$20.00K -$10.45K -$22.98K
YoY Change 0.0% -54.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.11M 77.40K 0.000
YoY Change 6469.57%
NET CHANGE
Cash From Operating Activities -3.110M -203.7K -649.3K
Cash From Investing Activities -20.00K -10.45K -22.98K
Cash From Financing Activities 15.11M 77.40K 0.000
Net Change In Cash 11.98M -136.8K -672.3K
YoY Change -2704.35% -79.66% 320.18%
FREE CASH FLOW
Cash From Operating Activities -$3.110M -$203.7K -$649.3K
Capital Expenditures -$20.00K $1.469K $2.751K
Free Cash Flow -$3.090M -$205.2K -$652.1K
YoY Change 375.38% -68.53% 307.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13896926
CY2018Q1 us-gaap Cash
Cash
24485
CY2017Q4 us-gaap Cash
Cash
161251
CY2018Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
838
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8844
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33074
CY2018Q1 us-gaap Assets Current
AssetsCurrent
58397
CY2017Q4 us-gaap Assets Current
AssetsCurrent
193574
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8326
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7804
CY2018Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1012106
CY2017Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
759591
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
307552
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
298569
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1319658
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1058160
CY2018Q1 us-gaap Assets
Assets
1386381
CY2017Q4 us-gaap Assets
Assets
1259538
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1149008
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
629074
CY2018Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
279288
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23479
CY2017Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
201890
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1428296
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
830964
CY2018Q1 gnpx Investment Unit
InvestmentUnit
0
CY2017Q4 gnpx Investment Unit
InvestmentUnit
0
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
11755
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
11721
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18092682
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17869205
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18146352
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17452352
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-41915
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
428574
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1386381
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1259538
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11755004
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11721584
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11755004
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11721584
CY2018Q1 us-gaap Revenues
Revenues
0
CY2017Q1 us-gaap Revenues
Revenues
0
CY2018Q1 us-gaap Depreciation
Depreciation
947
CY2017Q1 us-gaap Depreciation
Depreciation
597
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51621
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
68364
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
634063
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
682342
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
686631
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
751303
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-686631
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-751303
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
28
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2018Q1 us-gaap Interest Expense
InterestExpense
7398
CY2017Q1 us-gaap Interest Expense
InterestExpense
0
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-694001
CY2018Q1 gnpx Warrant Right To Purchase Percentage
WarrantRightToPurchasePercentage
0.80
CY2018Q1 gnpx Warrant Discount Rate
WarrantDiscountRate
0.20
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11738294
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11380881
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-751303
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8182
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9595
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4286
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
223512
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
233447
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8006
CY2018Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
252515
CY2017Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
28368
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
519934
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-116150
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-203712
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-649309
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1469
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2751
CY2018Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
8983
CY2017Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20227
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10452
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22978
CY2018Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
77398
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77398
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-136766
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-672287
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161251
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1602295
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24485
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
930008
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of our condensed financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p></div>
CY2018Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
6.6841954
CY2018Q1 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2018Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2017Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2018Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018Q1 gnpx Number Of Patents
NumberOfPatents
30
CY2018Q1 gnpx Number Of Pending Patents
NumberOfPendingPatents
2
CY2018Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4500000
CY2018Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08
CY2018Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-08-13
CY2018Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2018Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
33420
CY2018Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
If no event of default occurs prior to August 13, 2020, the Promissory Note and all related interest will be cancelled.
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2014Q1 gnpx Conversion Of Stock Shares Issued And Forward Stock Split
ConversionOfStockSharesIssuedAndForwardStockSplit
1235219
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2018Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
176650
CY2017 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
207206
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1095230
CY2017Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
150211
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M3D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2018Q1 gnpx Longterm Contract Estimated Cost
LongtermContractEstimatedCost
2000000
CY2018Q1 gnpx Royalty On Sales Percentage
RoyaltyOnSalesPercentage
0.01
CY2018Q1 gnpx Royalty Term
RoyaltyTerm
P21Y
CY2018Q1 gnpx Royalty Payment Annual Minimum
RoyaltyPaymentAnnualMinimum
20000
CY2018Q1 us-gaap Other Commitment
OtherCommitment
191393
CY2016 us-gaap Legal Fees
LegalFees
15393
CY2016Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
176000
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
140000
CY2017Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
36000
CY2017Q1 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
120000
CY2017Q1 gnpx Accrued Patent Costs Current
AccruedPatentCostsCurrent
36000
CY2017Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
20000
CY2016 us-gaap Other Expenses
OtherExpenses
36000
CY2017Q2 us-gaap Payments For Royalties
PaymentsForRoyalties
20000
CY2017Q2 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
240000
CY2017Q2 gnpx Contingent Payments Annual Increase
ContingentPaymentsAnnualIncrease
20000
CY2017Q1 gnpx Contingent Consideration Liability Operating Activities
ContingentConsiderationLiabilityOperatingActivities
240000
CY2017Q1 gnpx Fixed Contingent Consideration Liability Operating Activities
FixedContingentConsiderationLiabilityOperatingActivities
120000
CY2017Q1 us-gaap Finite Lived Intangible Assets Period Increase Decrease
FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
-120000
CY2017Q4 gnpx Percentage Applied On Outstanding Shares For Warrant To Purchase Shares Of Common Stock
PercentageAppliedOnOutstandingSharesForWarrantToPurchaseSharesOfCommonStock
0.03
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.34
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8000000

Files In Submission

Name View Source Status
0001564590-18-013661-index-headers.html Edgar Link pending
0001564590-18-013661-index.html Edgar Link pending
0001564590-18-013661.txt Edgar Link pending
0001564590-18-013661-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gnpx-10q_20180331.htm Edgar Link pending
gnpx-20180331.xml Edgar Link completed
gnpx-20180331.xsd Edgar Link pending
gnpx-20180331_cal.xml Edgar Link unprocessable
gnpx-20180331_def.xml Edgar Link unprocessable
gnpx-20180331_lab.xml Edgar Link unprocessable
gnpx-20180331_pre.xml Edgar Link unprocessable
gnpx-ex311_10.htm Edgar Link pending
gnpx-ex312_9.htm Edgar Link pending
gnpx-ex321_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending